Abstract
Polyglutamine disorders are neurodegenerative diseases that share a CAG repeat expansion in the coding region, resulting in aggregated proteins that can be only degraded through aggrephagy. We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington’s disease (HD), 20 with spinocerebellar ataxia type 2 (SCA2), and 20 healthy individuals. HD patients showed increased expression of MAP1LC3B (+ 43%; p = 0.048), SQSTM1 (+ 49%; p = 0.002), and WDFY3 (+ 89%; p < 0.001). SCA2 patients had increased expression of WDFY3 (+ 69%; p < 0.001). We show that peripheral markers of autophagy are elevated in polyQ diseases, and this is particularly evident in HD.
Change history
17 November 2017
Dr. Peluso’s given name and family name were initially interchanged inadvertently. The correct names have been corrected above. The original article was corrected.
References
La Spada AR, Taylor JP (2010) Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet 11:247–258
Huynh DP, Yang HT, Vakharia H, Nguyen D, Pulst SM (2003) Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. Hum Mol Genet 12:1485–1496
Brandstaetter H, Kruppa AJ, Buss F (2014) Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane. Dis Model Mech 7:1335–1340
Lee YK, Lee JA (2016) Role of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagy. BMB Rep 49:424–430
Katsuragi Y, Ichimura Y, Komatsu M (2015) p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J 282:4672–4678
Schmitz-Hübsch T, Giunti P, Stephenson DA et al (2008) SCA functional index: a useful compound performance measure for spinocerebellar ataxia. Neurology 71:486–492
Huntington Study group (1996) Unified Huntington’s disease rating scale: reliability and-consistency. Mov Disord 11:136–142
Saccà F, Marsili A, Puorro G et al (2013) Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene. J Neurol 260:1116–1121
Huynh DP, Figueroa K, Hoang N, Pulst SM (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 26:44–50
Rui YN, Xu Z, Patel B, Cuervo AM, Zhang SHTT (2015) Huntingtin in selective autophagy and Huntington disease: a foe or a friend within? Autophagy 11:858–860
Ashkenazi A, Bento CF, Ricketts T et al (2017) Polyglutamine tracts regulate autophagy. Autophagy 13:1613–1614
Sarkar S, Krishna G, Imarisio S, Saiki S, O'Kane CJ, Rubinsztein DCA (2008) Rational mechanism for combination treatment of Huntington’s disease using lithium and rapamycin. Hum Mol Genet 17:170–178
Author information
Authors and Affiliations
Contributions
Giorgia Puorro: Design and conceptualization of the study, Analysis or interpretation of the data and Drafting or revising the manuscript for intellectual content. Angela Marsili: Design and conceptualization of the study and Analysis or interpretation of the data. Francesca Sapone: Design and conceptualization of the study and Analysis or interpretation of the data. Chiara Pane: Analysis or interpretation of the data and Drafting or revising the manuscript for intellectual content. Anna De Rosa: Drafting or revising the manuscript for intellectual content. Peluso Silvio: Drafting or revising the manuscript for intellectual content. Giuseppe De Michele: Drafting or revising the manuscript for intellectual content. Alessandro Filla: Design and conceptualization of the study and Drafting or revising the manuscript for intellectual content. Francesco Saccà: Design and conceptualization of the study, Analysis or interpretation of the data and Drafting or revising the manuscript for intellectual content
Corresponding author
Ethics declarations
The local Ethics Committee of our institution approved the study (262/13). All patients gave written informed consent before any study activity.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
The original version of this article was revised: Dr. Peluso’s given name and family name were initially interchanged inadvertently.
A correction to this article is available online at https://doi.org/10.1007/s10072-017-3193-1.
Rights and permissions
About this article
Cite this article
Puorro, G., Marsili, A., Sapone, F. et al. Peripheral markers of autophagy in polyglutamine diseases. Neurol Sci 39, 149–152 (2018). https://doi.org/10.1007/s10072-017-3156-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-3156-6